Microdosing psilocybin for major depressive disorder: study protocol for a phase II double-blind placebo-controlled randomised partial crossover trial - CORRIGENDUM.
BJPsych Open May 13, 2026 Peer reviewed DOI: 10.1192/bjo.2026.12000 via PubMed Central
Abstract
Microdosing psilocybin for major depressive disorder: study protocol for a phase II double-blind placebo-controlled randomised partial crossover trial - CORRIGENDUM.